DEMENTIA Flashcards

1
Q

signs and symptoms of dementia

A
  • loss of cognitive ability
  • changes not associated with normal ageing
  • generally associated with progressive neurodegeneration
  • finding it hard to follow conversations
  • repeating yourself
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

stages of dementia - mild

A
  • increasingly noticeable memory loss, cognitive impairment
  • has ability to cover this up
  • may be normal ageing in older people
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

stages of dementia - moderate

A
  • memory lapses and confusion becomes more obvious
  • personality and mental ability changes, some physical problems may develop
  • repeated reminders for everyday functions - eat. toilet etc.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

stages of dementia - severe

A
  • memory and personality deteriorate further
  • impaired ability to communicate
  • become dependent on others
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

multiple causes of dementia

A
  • Alzheimer’s disease
  • Parkinson’s disease
  • dementia with Lewy bodies
  • vascular dementia
  • frontotemporal dementia (FTD)
  • mixed dementia
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

diagnosing tests for dementia

A
  • mini-mental state examination (MMSE)
  • memory impairment screen (MIS)
  • eight-item informant interview to differentiate ageing and dementia (AD8)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Alzheimer’s disease diagnosis

A
  • progressive decline in cognitive ability
  • regular visits to GP and memory clinics
  • no definitive diagnostic test
  • postmortem associated with plaques (amyloid) and neurofibrillary tangles (Tau)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

vascular dementia diagnosis

A
  • CT or MRI scans
  • reduced blood flow to brain
  • able to rule out other conditions that may have similar symptoms
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

dementia with Lewy bodies diagnosis

A
  • SPECT scan - more sensitive than CT and MRI
  • neuronal deposits of a-synuclein
  • CT or MRI scans to rule out other conditions that may have similar symptoms
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

frontotemporal dementia (FTD) diagnosis

A
  • usually affects people 45-64 years old
  • CT or MRI scans to identify damage to frontal and temporal lobes
  • tauopathy
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

plaques around neurons are…

A

extracellular
(amyloid beta protein)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

tangles within neurons are…

A

intracellular
(Tau protein)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

suggested roles of amyloid

A
  • angiogenesis (vascular plug)
  • antimicrobial peptide
  • tumour suppression
  • LTP (learning and memory)
  • regulates hyperexcitability
  • neurogenesis/survival
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

suggested roles of Tau

A
  • iron homeostasis
  • promotes myelination
  • permits hyperexcitability
  • motor control
  • sleep-wake cycle
  • neurogenesis/synaptogenesis
  • axon transport
  • insulin signalling
  • transcription/protects DNA
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

what goes wrong

A

APP cleaved B secretase followed by Y secretase = AB = toxicity

incorrect cleavage of amyloid precursor protein (APP) by secretases

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

hyperphosphorylation of Tau

A
  • usually not highly phosphorylated and does not aggregate
  • tauopathies linked to many diseases
  • FTD is a tauopathy
17
Q

first-line treatment for mild to moderate Alzheimer’s disease

A

AchE inhibitors:
donepezil
rivastigmine
galantamine

18
Q

dosage for AchE inhibitors in AD

A
  • donepezil
  • 5mg daily at bedtime
  • increased to 10mg after 1 month if no side effects
19
Q

side effects of AchE inhibitors

A

diarrhoea
muscle cramps
fatigue
nausea
vomiting
insomnia

20
Q

first-line treatment for severe Alzheimer’s disease

A

non-competitive NMDA antagonist:
- memantine
- can be given in moderate AD if AchE inhibitors are not tolerated

21
Q

dosage for non-competitive NMDA antagonist in AD

A
  • memantine
  • 5mg once daily
  • increased weekly to max 20mg
22
Q

side effects of non-competitive NMDA antagonist

A

dizziness
headache
constipation
somnolence
hypertension

23
Q

evidence for memantine

A
  • medium affinity for NMDA affinity
  • voltage-dependent channel blocker
  • prolonged low levels stimulation via increased glutamate in AD, memantine blocks NMDA receptor
  • transient high levels of glutamate i.e. synaptic transmission - memantine block relieved
  • high affinity channel blockers
24
Q
A